| 2026-03-02 | Mr. Ramy TadrosRegional President of U.S. Business & Head of MetLife Holdings | -5,17k | 378,36k | Sale to Issuer | 73,24 | 179,60k | -2,80% |
| 2026-03-02 | Mr. Michel Abbas KhalafCEO, President & Director | -22,42k | 1,64M | Sale to Issuer | 73,24 | 578,41k | -3,73% |
| 2026-03-02 | Ms. Marlene Beverly DebelExec. VP, Chief Risk Officer & Head of Insurance Investments | -4,13k | 302,70k | Sale to Issuer | 73,24 | 126,11k | -3,17% |
| 2026-03-02 | Mr. John Dennis McCallionExec. VP, CFO & Head of Investment Management | -6,99k | 511,58k | Sale to Issuer | 73,24 | 275,19k | -2,48% |
| 2026-03-02 | Ms. Monica M. CurtisExec. VP & Chief Legal Officer | -953,00 | 69,80k | Sale to Issuer | 73,24 | 17,65k | -5,12% |
| 2026-03-02 | Ms. Shurawl SibbliesExec. VP & Chief HR Officer | -220,00 | 16,11k | Sale to Issuer | 73,24 | 7,08k | -3,02% |
| 2026-03-02 | Mr. Bill PappasExec. VP and Head of Global Technology & Operations | -5,99k | 438,63k | Sale to Issuer | 73,24 | 63,18k | -8,66% |
| 2026-02-24 | Mr. Ramy TadrosRegional President of U.S. Business & Head of MetLife Holdings | -2,30k | 173,21k | Sale to Issuer | 75,34 | 173,00k | -1,31% |
| 2026-02-24 | Ms. Marlene Beverly DebelExec. VP, Chief Risk Officer & Head of Insurance Investments | -5,62k | 423,71k | Sale to Issuer | 75,34 | 122,15k | -4,40% |
| 2026-02-24 | Mr. John Dennis McCallionExec. VP, CFO & Head of Investment Management | -13,78k | 1,04M | Sale to Issuer | 75,34 | 223,69k | -5,80% |
| 2026-02-24 | Mr. Michel Abbas KhalafCEO, President & Director | -43,00k | 3,24M | Sale to Issuer | 75,34 | 560,29k | -7,13% |
| 2026-02-24 | Mr. Bill PappasExec. VP and Head of Global Technology & Operations | -11,68k | 880,20k | Sale to Issuer | 75,34 | 69,17k | -14,45% |
| 2026-02-24 | Ms. Monica M. CurtisExec. VP & Chief Legal Officer | -237,00 | 17,86k | Sale to Issuer | 75,34 | 18,60k | -1,26% |
| 2025-07-31 | MetLife, Inc.Unternehmen | -1,69M | 0,00 | Verkauf | - | 106,55M | -1,56% |
| 2025-10-31 | Ms. Monica M. CurtisExec. VP & Chief Legal Officer | -4,42k | 352,80k | Sale to Issuer | 79,82 | 10,45k | -29,72% |
| 2025-04-28 | MetLife, Inc.Unternehmen | -1,16M | 0,00 | Verkauf | - | 108,24M | -1,06% |